Unique Ingredient Identifier 506T60A25R is listed as a ingredient substance
RN | 50-70-4 |
EC | 200-061-5 |
NCIT | C29462 |
RXCUI | 9945 |
PUBCHEM | 5780 |
MF | C6H14O6 |
INCHI KEY | FBPFZTCFMRRESA-JGWLITMVSA-N |
SMILES | OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO |
UNII 506T60A25R SORBITOL is commonly included in medications in the following forms.
Route | Dosage Form | Potency |
---|---|---|
BUCCAL | GUM, CHEWING | 257 MG |
DENTAL | PASTE | NA |
INTRA-ARTICULAR | INJECTION | 84.83 % |
INTRALESIONAL | INJECTION | 45 % |
INTRAMUSCULAR | INJECTION | 84.83 % |
INTRASYNOVIAL | INJECTION | 84.83 % |
INTRAVENOUS | INJECTION | 45 MG/1ML |
INTRAVENOUS | INJECTION | 30 % |
INTRAVENOUS | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED | 5.43 % |
INTRAVENOUS | SOLUTION, INJECTION | 48 % |
IV(INFUSION) | INJECTABLE | 4.7 % |
IV(INFUSION) | INJECTION | 30 % |
IV(INFUSION) | SOLUTION, INJECTION | 7.14 % |
NASAL | SOLUTION | 2.5 % |
NASAL | SPRAY | 6165 MCG/SPRAY |
NASAL | SPRAY | 4.55 % |
NASAL | SPRAY, METERED | 6.45 % |
OPHTHALMIC | SOLUTION | 4.6 % |
OPHTHALMIC | SOLUTION, DROPS | 0.25 % |
ORAL | BAR, CHEWABLE | NA |
ORAL | CAPSULE | 185.18 MG |
ORAL | CAPSULE, SOFT GELATIN | 113.6 MG |
ORAL | CAPSULE, SOFT GELATIN LIQUID-FILLED | NA |
ORAL | CONCENTRATE | 400 MG/1ML |
ORAL | DROPS | 30 MG/1ML |
ORAL | GRANULE, FOR SUSPENSION | 28 MG |
ORAL | GUM, CHEWING | 257 MG |
ORAL | LIQUID | 286 MG/5ML |
ORAL | POWDER | 11.147 MG/BOTTLE |
ORAL | POWDER | 5 % |
ORAL | POWDER, FOR SUSPENSION | 342.84 MG/1ML |
ORAL | POWDER, FOR SUSPENSION | 0.15 g/236mL |
ORAL | SOLUTION | 335 MG/5ML |
ORAL | SOLUTION, ELIXIR | 33 % |
ORAL | SOLUTION, LIQUID | 0.005 %V/V |
ORAL | SUSPENSION | 184.14 MG/1ML |
ORAL | SUSPENSION, LIQUID | 2000 MG/5ML |
ORAL | SYRUP | 71.2 % |
ORAL | TABLET | 337.28 MG |
ORAL | TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE | 316 MG |
ORAL | TABLET, COATED | 12.96 MG |
ORAL | TABLET, DELAYED ACTION, ENTERIC COATED | NA |
ORAL | TABLET, EXTENDED RELEASE | 47.4 MG |
ORAL | TABLET, FILM COATED | 5 MG |
ORAL | TABLET, ORALLY DISINTEGRATING | 7 MG |
ORAL | TABLET, SUSTAINED ACTION | 53.75 MG |
RECTAL | SUSPENSION | 33.33 % |
SUBCUTANEOUS | INJECTABLE | 4.7 % |
SUBCUTANEOUS | SOLUTION, INJECTION | 4.7 % |
SUBLINGUAL | TABLET | 50.5 MG |
TOPICAL | CREAM | 10 %W/W |
TOPICAL | EMULSION | 7 %W/W |
TOPICAL | EMULSION, CREAM | 5 %W/W |
TOPICAL | LIQUID | 9.6 %W/W |
TOPICAL | LOTION | NA |
TOPICAL | OINTMENT | 10 %W/W |
TOPICAL | SOLUTION | 4.6 %W/V |
VAGINAL | INSERT | 55.1 MG |
VAGINAL | TABLET | NA |
BUCCAL | GUM, CHEWING | 45 MG |
INTRA-ARTICULAR | INJECTION | 84.83 % |
INTRALESIONAL | INJECTION | NA |
INTRAMUSCULAR | INJECTION | 84.83 % |
INTRASYNOVIAL | INJECTION | 84.83 % |
INTRAVENOUS | INJECTION | 7.14 % |
INTRAVENOUS | SOLUTION, INJECTION | 7.14 % |
IV(INFUSION) | SOLUTION, INJECTION | 7.14 % |
NASAL | SPRAY, METERED | 8836.5 MCG/SPRAY |
NASAL | SPRAY, METERED | 0.006 % |
OPHTHALMIC | SOLUTION | 6.7 % |
ORAL | CAPSULE | 95 MG |
ORAL | CAPSULE, COATED, SOFT GELATIN | 3.11 MG |
ORAL | CAPSULE, SOFT GELATIN | 80 MG |
ORAL | CAPSULE, SOFT GELATIN LIQUID-FILLED | 97 MG |
ORAL | CONCENTRATE | 600 MG/1ML |
ORAL | DROPS | 50 MG/1ML |
ORAL | GUM, CHEWING | 45 MG |
ORAL | LIQUID | 2970 MG/5ML |
ORAL | ORAL SOLUTION DOSAGE FORM | 1350 mg/5mL |
ORAL | SOLUTION | 2142.83 MG/5ML |
ORAL | SOLUTION, CONCENTRATE | 300 MG/1ML |
ORAL | SOLUTION, ELIXIR | 75 % |
ORAL | SOLUTION, SYRUP | 500 MG/1ML |
ORAL | SUSPENSION | 4012.5 MG/15ML |
ORAL | SUSPENSION | 3570 MG/5ML |
ORAL | SUSPENSION | 571.43 mg/1mL |
ORAL | SUSPENSION | 62.5 mg/1.25mL |
ORAL | SUSPENSION, DROPS | 250 MG/1ML |
ORAL | SUSPENSION, LIQUID | 2000 MG/5ML |
ORAL | SUSPENSION, SYRUP, SUSTAINED ACTION | 2 % |
ORAL | SYRUP | 4370 MG/5ML |
ORAL | TABLET | 14 MG |
RECTAL | SUSPENSION | 46.18 % |
TOPICAL | CREAM | 17.5 MG/1G |
TOPICAL | CREAM | 13.5 %W/W |
TOPICAL | CREAM, AUGMENTED | 15 %W/W |
TOPICAL | CREAM, EMULSION, SUSTAINED RELEASE | 36.8 %W/W |
TOPICAL | EMULSION, CREAM | 25 %W/W |
TOPICAL | FILM, CONTROLLED RELEASE | 2800 MG |
TOPICAL | LOTION | 5 %W/W |
TOPICAL | OINTMENT | 1.5 %W/W |
TOPICAL | PATCH | 2240 MG |
TOPICAL | PATCH, CONTROLLED RELEASE | NA |
TOPICAL | SOLUTION, DROPS | 6.9 %W/V |
VAGINAL | CREAM, EMULSION, SUSTAINED RELEASE | 36.8 %W/W |
VAGINAL | EMULSION, CREAM | 36.8 % |